ATE457733T1 - Lipid-a- und andere kohlenhydrat-liganden-analoga - Google Patents

Lipid-a- und andere kohlenhydrat-liganden-analoga

Info

Publication number
ATE457733T1
ATE457733T1 AT03726743T AT03726743T ATE457733T1 AT E457733 T1 ATE457733 T1 AT E457733T1 AT 03726743 T AT03726743 T AT 03726743T AT 03726743 T AT03726743 T AT 03726743T AT E457733 T1 ATE457733 T1 AT E457733T1
Authority
AT
Austria
Prior art keywords
lipid
analogs
useful
replacement
nature
Prior art date
Application number
AT03726743T
Other languages
English (en)
Inventor
Zi-Hua Jiang
R Koganty
Wladyslaw Budzynski
Original Assignee
Oncothyreon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncothyreon Inc filed Critical Oncothyreon Inc
Application granted granted Critical
Publication of ATE457733T1 publication Critical patent/ATE457733T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06Fatty acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT03726743T 2002-05-09 2003-05-09 Lipid-a- und andere kohlenhydrat-liganden-analoga ATE457733T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37864502P 2002-05-09 2002-05-09
PCT/US2003/014633 WO2003094850A2 (en) 2002-05-09 2003-05-09 Lipid a and other carbohydrate ligand analogs

Publications (1)

Publication Number Publication Date
ATE457733T1 true ATE457733T1 (de) 2010-03-15

Family

ID=29420423

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03726743T ATE457733T1 (de) 2002-05-09 2003-05-09 Lipid-a- und andere kohlenhydrat-liganden-analoga

Country Status (9)

Country Link
US (2) US7820627B2 (de)
EP (1) EP1549322B1 (de)
JP (1) JP5014573B2 (de)
AT (1) ATE457733T1 (de)
AU (1) AU2003228966C1 (de)
CA (1) CA2485253C (de)
DE (1) DE60331330D1 (de)
ES (1) ES2343788T3 (de)
WO (1) WO2003094850A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004533421A (ja) 2001-03-27 2004-11-04 バイオミラ,インコーポレイテッド T1免疫応答とt2免疫応答との間で調節するためのワクチン
ATE457733T1 (de) 2002-05-09 2010-03-15 Oncothyreon Inc Lipid-a- und andere kohlenhydrat-liganden-analoga
TW201204410A (en) 2004-04-01 2012-02-01 Oncothyreon Inc Mucinous glycoprotein (MUC-1) vaccine
JP5364371B2 (ja) 2005-06-28 2013-12-11 オンコセリオン インコーポレイテッド ムチン糖タンパク質(muc−1)ワクチンによって患者を処置する方法
US8568705B2 (en) 2005-07-18 2013-10-29 Nektar Therapeutics Method for preparing branched functionalized polymers using branched polyol cores
ITMI20060530A1 (it) * 2006-03-22 2007-09-23 Univ Milano Bicocca Antinfiammatori a struttura monosaccaridica
US9115358B2 (en) 2006-08-11 2015-08-25 President And Fellows Of Harvard College Moenomycin biosynthesis-related compositions and methods of use thereof
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
KR101378872B1 (ko) 2006-09-26 2014-04-11 인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) 합성 애주번트를 함유하는 백신 조성물
KR101012587B1 (ko) * 2007-06-04 2011-02-01 엘지전자 주식회사 디스플레이 장치
EP2205074A4 (de) * 2007-10-04 2013-07-31 Harvard College Moenomycin-analoga, syntheseverfahren und verwendung
EP3936122A1 (de) 2008-11-24 2022-01-12 Massachusetts Institute Of Technology Verfahren und zusammensetzung zur lokalen wirkstoffabgabe
SI2437753T1 (sl) 2009-06-05 2016-12-30 Infectious Disease Research Institute Sintetični glukopiranozil-lipidni adjuvansi in cepivni sestavki, ki jih vsebujejo
CN102329335B (zh) * 2010-07-13 2014-01-22 哈尔滨工业大学 基于季戊四醇的复合脂质,制备方法及用途
WO2011115684A2 (en) 2010-03-19 2011-09-22 Massachusetts Institute Of Technology Lipid vesicle compositions and methods of use
US20110229556A1 (en) * 2010-03-19 2011-09-22 Massachusetts Institute Of Technology Lipid-coated polymer particles for immune stimulation
US9149432B2 (en) 2010-03-19 2015-10-06 Massachusetts Institute Of Technology Lipid vesicle compositions and methods of use
CN105193724A (zh) * 2011-02-24 2015-12-30 肿瘤防护公司 含有佐剂的以muc1 为基础的糖脂肽疫苗
AU2012243039B2 (en) 2011-04-08 2017-07-13 Immune Design Corp. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
US9273084B2 (en) 2012-04-06 2016-03-01 President And Fellows Of Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
WO2013151697A1 (en) 2012-04-06 2013-10-10 President And Fellows Of Harvard College Methods and compounds for identifying glycosyltransferase inhibitors
EP2850090B1 (de) 2012-04-06 2018-10-03 President and Fellows of Harvard College Chemoenzymatische verfahren zur synthetisierung von moenomycin-analoga
PT2850431T (pt) 2012-05-16 2018-07-23 Immune Design Corp Vacinas para hsv-2
EP3711768A1 (de) 2013-04-18 2020-09-23 Immune Design Corp. Gla-monotherapie zur verwendung in der krebsbehandlung
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
CA2925304C (en) 2013-09-27 2023-04-18 Massachusetts Institute Of Technology Carrier-free biologically-active protein nanostructures
CN107531736B (zh) * 2015-01-06 2022-04-15 免疫疫苗科技公司 脂质a模拟物、其制备方法和用途
AU2016305087B2 (en) 2015-08-12 2022-01-20 Massachusetts Institute Of Technology Cell surface coupling of nanoparticles
US11472856B2 (en) 2016-06-13 2022-10-18 Torque Therapeutics, Inc. Methods and compositions for promoting immune cell function
KR20210032924A (ko) 2017-09-05 2021-03-25 토크 테라퓨틱스, 인코포레이티드 치료용 단백질 조성물 및 그의 제조 및 사용 방법
PL3752182T3 (pl) 2018-02-12 2024-11-25 Inimmune Corporation Ligandy receptorów toll-podobnych
CN117480160A (zh) * 2021-05-31 2024-01-30 三菱瓦斯化学株式会社 新型氨基化合物和其制造方法、以及使用其的环氧树脂用固化剂、环氧树脂组合物和环氧树脂固化物
CN114399151B (zh) * 2021-11-29 2026-02-03 阿里巴巴创新公司 运力订单分配方法、装置、可读程序产品及导航方法
CN116162115B (zh) * 2022-12-27 2025-09-26 华中师范大学 Toll样受体4免疫激动剂及其应用、抗病毒疫苗分子及其制备方法和应用
KR102827958B1 (ko) 2025-04-09 2025-07-03 주식회사 로우맵 피부흡수 촉진용 히알루론산 나노캡슐, 이의 제조방법 및 이를 포함한 화장료 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB614215A (en) * 1946-07-09 1948-12-10 Leslie Bradford Manufacture of polyureas
GB699080A (en) 1950-05-31 1953-10-28 Ici Ltd Production of new esters of ortho-phosphoric acid and salts thereof
US3930024A (en) * 1969-09-02 1975-12-30 Parke Davis & Co Pharmaceutical compositions and methods
DE3127503A1 (de) 1981-07-11 1983-02-17 Boehringer Mannheim Gmbh, 6800 Mannheim Neue phospholipide, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4464383A (en) 1981-11-24 1984-08-07 Itaru Yamamoto Immunomodulator containing trithiazole pentamethine cyanine derivative
US4783402A (en) * 1983-04-11 1988-11-08 Meito Sangyo Kabushiki Kaisha Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique
GR860379B (en) * 1985-02-22 1986-06-11 Akzo Nv Novel disaccharide and trisaccharide derivatives of the lipid a type
EP0219514A4 (de) 1985-04-03 1988-04-26 Wisconsin Alumni Res Found Verfahren zum vorbeugen von krankheiten, verursacht durch gram-negatives endotoxin bei säugetieren.
JPS63139186A (ja) 1986-11-29 1988-06-10 Hidetoshi Tsuchida 三本鎖型リン脂質化合物およびその製造方法
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5041427A (en) * 1989-07-21 1991-08-20 Wisconsin Alumni Research Foundation Lipid A derivatives
JPH0655749B2 (ja) 1989-09-20 1994-07-27 日本たばこ産業株式会社 リピッドa単糖類縁体
FR2702306B1 (fr) 1993-03-05 1995-04-14 Alcatel Nv Procédé d'auto-alignement d'un contact métallique sur un substrat de matériau semi-conducteur.
IT1264690B1 (it) 1993-07-08 1996-10-04 Bracco Spa Compositi oligomeri iodurati e composizioni diagnostiche contenenti gli stessi
DE4408248A1 (de) 1994-03-11 1995-09-14 Hoechst Ag Physiologisch verträgliche und physiologisch abbaubare Kohlenhydrat-Mimetika, ein Verfahren zur Herstellung und ihre Verwendung
AU2247095A (en) 1994-04-12 1995-10-30 Biomira Inc. Cellular immune response-specific antigens and uses therefor
US6764840B2 (en) 1997-05-08 2004-07-20 Corixa Corporation Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
IT1295460B1 (it) 1997-10-02 1999-05-12 Borgotec Tecnologie Autom Spa Metodo per impilare pacchi di piastre di circuiti stampati e relativo dispositivo di carico e scarico di pacchi per una macchina utensile.
US6043390A (en) 1998-04-03 2000-03-28 The Regents Of The University Of California Pentaerythritol lipid derivatives and nucleic-acid complexes
AU5280999A (en) * 1998-07-21 2000-02-14 Lonza A.G. Method for producing amines
AU780577B2 (en) 1999-11-15 2005-04-07 Oncothyreon Inc. Synthetic Lipid-A analogs and uses thereof
US6699846B2 (en) 2000-03-17 2004-03-02 Corixa Corporation Mono- and disaccharides for the treatment of nitric oxide related disorders
ES2164013B1 (es) 2000-04-14 2003-06-16 Consejo Superior Investigacion Glicosidos de n-acetil-6-o-(2,2-bis(hidroximetil)-3-hidroxipropil)-d-glucosamina, procedimiento de obtencion y uso en el tratamiento de tumores cerebrales.
AU2003203079B8 (en) * 2002-02-04 2009-01-15 Oncothyreon Inc. Immunostimulatory, covalently lipidated oligonucleotides
US20060069238A1 (en) 2002-04-15 2006-03-30 Biomira, Inc. Synthetic glyco-lipo-peptides as vaccines
ATE457733T1 (de) 2002-05-09 2010-03-15 Oncothyreon Inc Lipid-a- und andere kohlenhydrat-liganden-analoga

Also Published As

Publication number Publication date
JP5014573B2 (ja) 2012-08-29
EP1549322B1 (de) 2010-02-17
JP2005538050A (ja) 2005-12-15
WO2003094850A3 (en) 2004-07-29
WO2003094850A2 (en) 2003-11-20
CA2485253A1 (en) 2003-11-20
AU2003228966B2 (en) 2009-10-01
AU2003228966C1 (en) 2010-05-13
US20120003295A1 (en) 2012-01-05
AU2003228966A1 (en) 2003-11-11
CA2485253C (en) 2012-07-10
US7820627B2 (en) 2010-10-26
US20060040891A1 (en) 2006-02-23
DE60331330D1 (de) 2010-04-01
EP1549322A2 (de) 2005-07-06
US8097593B1 (en) 2012-01-17
EP1549322A4 (de) 2006-07-26
ES2343788T3 (es) 2010-08-10

Similar Documents

Publication Publication Date Title
EP1549322A4 (de) Lipid-a- und andere kohlenhydrat-liganden-analoga
PT665886E (pt) Rearranjo de complexos de ciclina e suas utilizacoes
IL169896A0 (en) Methods and compositions for administering therapeutic and diagnostic agents
BR0312764A (pt) Cardiomiócitos funcionais originados de células-tronco embrionárias humanas
ATE469670T1 (de) Verbindungsmodul für eine modulare implantierbare medizinische vorrichtung
ATE358723T1 (de) Nukleinsäuresequenzen für proteine die an der isoprenoid-synthese beteiligt sind
PE20110358A1 (es) Metodos y composiciones para el tratamiento de defectos oseos con poblaciones de celulas placentarias
ATE273662T1 (de) Implantat für osteosynthesen
EA200100773A1 (ru) Замещенные 1-гетероциклические диариламины
BRPI9912227B1 (pt) método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método.
GB2458430A (en) Method for generating a reference signal sequence using grouping
DE50312069D1 (de) Segment für einen sensorträgerkörper eines molches
WO2003029418A3 (en) Proliferation and differentiation of stem cells using extracellular matrix and other molecules
NO20065084L (no) Interferon-alfa polypeptider og konjugater
BR0109062A (pt) Inibidores de frutose-1,6-bisfosfatase de arila
IL152111A0 (en) Tamandarin and didemnin analogs and methods of making and using them
GB0308910D0 (en) Methods for measuring enzyme activity
ATE379870T1 (de) Motorgehäuse
ATE497976T1 (de) Spezifisch an vygfvracl-hla-a24 bindende t-zellen-rezeptoren
WO2004030621A3 (en) Method of treating cancer using adenosine and its analogs
WO2004108887A3 (en) Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
BRPI0514074A (pt) aperfeiçoamentos em composições em bloco para lavatório
EP1601687A4 (de) Verfahren zur erhöhung der ausbreitung von b-zellen
AU2003288621A8 (en) Rna bioassay
BR112012022339A2 (pt) óleos biológicos ou biocombustíveis e organismo isolado e método para produzir os mesmos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1549322

Country of ref document: EP